It's Time for Patients to Drive Healthcare ResearchWhen the new CHEERS report was released, we were pleased to see the updated standards regarding patient and stakeholder engagement. These standards reflect a growing recognition that patient and stakeholder engagement need to be incorporated into economic evaluations and healthcare research from the conceptualization stage rather than as [...]
When the updated CHEERS report((Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force. Value In Health. 2022;25(1):10-31.)) encouraged the use of health economic analysis plans (HEAP), we saw this as an opportunity [...]
Author: Jennifer Bright, MPA, Executive Director, IVI For decades, we've known that untreated or poorly treated Major Depressive Disorder (MDD) is an enormous burden on individual patients, our health care system, and our society. Despite having this knowledge, there is much work to do in order to support and optimize cost-effective care for patients suffering [...]
Authors: Patricia Deverka, Jennifer Bright, Louis Garrison, Samuel Nussbaum We have seen the COVID-19 pandemic decimate people’s lives, health care systems, and the global and US economy, with investments by the US government exceeding $4 trillion dollars and with unemployment approaching 20%. In recent days, numerous articles have speculated on the pricing for Gilead’s new [...]
In a Morning Consult commentary, IVI Executive Director, Jennifer Bright, discusses why transparency is a prerequisite to value-based reimbursement and how IVI's Open-Source Value Platform (OSVP) is an open laboratory for creating sophisticated systems to assess value in healthcare. Read the full article here.
In an article published online by the American Journal of Managed Care, IVI's Executive Director, Jennifer Bright, and Director of Scientific Communications, Mark Linthicum, offer five predictions for where value assessment is headed in 2019. Specifically, Jennifer and Mark focus their discussion on the following areas of interest regarding value assessment: Including patient perspectives becomes [...]
In an op-ed published in Healthcare Business News, IVI's Executive Director, Jennifer Bright, describes four essential steps necessary to better measure value in healthcare: Better value measurement must incorporate the patient perspective into all assessment tools. Real world data must be considered when determining a treatment's worth beyond direct clinical benefit. Value assessments must be [...]
IVI's Director of Research, Jason Shafrin, contributes to an op-ed for The Washington Post's "In Theory Blog: How we should pay for cures, according to economics." In the commentary, Dr. Shafrin uses the example of a cure for Alzheimer's disease to illustrate how various stakeholders demand very different pricing structures, and how IVI is working to [...]